Advertisement
Advertisement

NCNA

NCNA logo

NuCana plc - ADR

1.27
USD
-0.01
-0.78%
Dec 18, 13:47 UTC -5
Open

NuCana plc - ADR Profile

About

NuCana PLC is a clinical-stage biopharmaceutical company. It focused on improving treatment outcomes for cancer patients by applying its phosphoramidate chemistry technology. The company's pipeline of products includes Acelarin, NUC-3373 and NUC-7738 which are in clinical stage. NuCana PLC is based in EDINBURGH, United Kingdom.

Info & Links

CEO

Hugh Griffith

Headquarters

3 Lochside Way
Edinburgh, X0 EH12 9DT, UNITED KINGDOM

Industry

Biotechnology

Sector

Health Technology

Website

www.nucana.com

Auditor

Ernst & Young LLP

Share holders

--

Employees

28

NuCana plc - ADR Statistics

Valuation Measures

Market Capitalization2

3.35M

Enterprise Value

-11.34M

Enterprise Value/EBITDA(ttm)

0.27

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.59

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-314.47%

Return on Invested Capital(ttm)

-406.96%

Return on Assets(ttm)

-112.60%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-42.28M

Net Income Available to Common(ttm)

-35.54M

Diluted EPS(ttm)

-10.48

Share Statistics

Beta (5Y Monthly)

0.94

52-Week Change

-87.07%

S&P 500 52-Week Change

26.69%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

1.82M

% Held by Insiders

31.20%

% Held by Institutions

44.00%

Balance Sheet

Total Cash(mrq)

14.69M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.12%

Quick Ratio(mrq)

1.12%

Book Value Per Share(mrq)

0.06

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.25

Free Cash Flow(ytd)

-15.17M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement